Welcome to the Boehnke Lab!
Integrating biology, engineering, and data science to advance the translation of nanomedicine
Our group uses experimental and computational tools to gain a fundamental understanding of the nano-bio interface, focusing on identifying and leveraging both the materials properties and biological features needed for successful drug delivery. Specifically, using biological, chemical, and engineering approaches, we develop and utilize toolsets that enable high throughput and pooled screening of nanocarriers. Using data science approaches, we also leverage large omics datasets to gain insight into biological interactions with nanomaterials. Taken together, our research allows us to take a holistic approach to understanding and advancing nanomedicine.
We are dedicated to creating a safe, inclusive, and collaborative space to study the fundamentals of drug delivery together.
We are funded by the University of Minnesota, the NIH, the Minnesota Ovarian Cancer Alliance and the Data Science Initiative (DSI)!
